Mid-Year Amendment

TIBER CREEK GROUP for AMGEN INC

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$80,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
Mid-Year Report Jul 27, 2007 $80,000 Replaced
Mid-Year Amendment (this page) Aug 13, 2007 $80,000 Replaced
Mid-Year Amendment Aug 13, 2007 $80,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Intellectual Property and Process Patent Issues

LobbyistCovered position, as disclosed
JANET MULLINS GRISSOM N/A
DAVID E JOHNSON N/A
JONATHON JONES COS, SEN. CARPER
JEFFREY PECK N/A

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

HR.2900, Food and Drug Administration Amendments Act of 2007.

LobbyistCovered position, as disclosed
JANET MULLINS GRISSOM N/A
DAVID E JOHNSON N/A
JONATHON JONES COS, SEN. CARPER
JEFFREY PECK N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2900 (110th)

Medicare/Medicaid MMM

Medicare Coverage and Reimbursement of Erthropoiesis-Stimulating

LobbyistCovered position, as disclosed
JANET MULLINS GRISSOM N/A
DAVID E JOHNSON N/A
JONATHON JONES COS, SEN. CARPER
JEFFREY PECK N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.